(Q35000771)

5 August 2017

title

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance (English)

1 reference

5 August 2017

1 reference

K L Bigos

1

1 reference

5 August 2017

R R Bies

2

1 reference

5 August 2017

B G Pollock

3

1 reference

5 August 2017

J J Lowy

4

1 reference

5 August 2017

F Zhang

5

1 reference

5 August 2017

D R Weinberger

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

26 April 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

620-625

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2011.38

5 August 2017

exact match

0 references

cites work

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Genomewide association for schizophrenia in the CATIE study: results of stage 1

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

PLINK: a tool set for whole-genome association and population-based linkage analyses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Sequence diversity and haplotype structure at the human CYP3A cluster

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Dose response and dose equivalence of antipsychotics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

The International HapMap Project

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Pharmacogenomics: translating functional genomics into rational therapeutics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100476

Sex, race, and smoking impact olanzapine exposure.

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.38

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.38

Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.38

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.38

International consensus study of antipsychotic dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.38

Clinical outcome and olanzapine plasma levels in acute schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.38

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21519338

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21519338

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/MP.2011.38

1 reference

5 August 2017

1 reference

5 August 2017

1 reference